Publications by authors named "Angadbir S Parmar"

Article Synopsis
  • - Clostridioides difficile infection (CDI) is a prevalent hospital-acquired infection, with rising cases in the community, particularly affecting elderly patients with high morbidity and mortality rates.
  • - First-line treatments for CDI include oral Vancomycin and Fidaxomicin; however, Vancomycin has poor gastrointestinal absorption, leading to negligible systemic bioavailability, and there are limited reports of adverse reactions.
  • - A case is presented of a 66-year-old man who developed a rash and leukocytosis after starting oral Vancomycin for severe CDI; symptoms improved rapidly after discontinuation of the drug, highlighting the need for clinicians to be aware of potential rare adverse reactions.
View Article and Find Full Text PDF